The latest immunotherapy news and developments
PD-L1 checkpoint inhibitors are a powerful and growing form of immunotherapy used to treat melanoma,…
By Bendta Schroeder, Massachusetts Institute of Technology As cancer cells progress, they accumulate hundreds and…
A team at Fred Hutchinson Cancer Research Center has identified a gene that could make…
By Jess Reid, University of Western Australia A research project led by The University of…
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people…
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
Immunotherapy is a revolutionary cancer treatment, but it was unknown if cancer patients with HIV…
Igor Puzanov, MD, Director of the Early Phase Clinical Trials Program and Chief of Melanoma…
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…